Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 2022 Feb 14;150:e47. doi: 10.1017/S0950268822000061

The prevalence of hepatitis B virus infection in Bangladesh: a systematic review and meta-analysis

Sujan Banik 1,✉, Anamika Datta 1, Antara Ghosh 1, Kanak Yadab Ghosh 2, Hoimonti Debi 1
PMCID: PMC8895722  PMID: 35156592

Abstract

Despite the availability of an effective vaccine, hepatitis B virus (HBV) infection is one of the major public health problems worldwide, mostly in developing countries. This systematic review and meta-analysis were performed to estimate the pooled prevalence of HBV infection in Bangladesh. We systematically searched various electronic databases to retrieve relevant studies published until April 2021. A total of 15 studies were met the inclusion criteria and included in the meta-analysis. The pooled estimated prevalence of HBV infection in the general population of Bangladesh from 1995 to 2017 was 4.0% [95% confidence interval (CI) 3.0–5.1]. The results of subgroup analysis revealed that the prevalence of hepatitis B was higher in females than males [odds ratio (OR) 1.20, 95% CI 0.48–2.97, P = 0.70], people of age <25 years had a higher prevalence than people of age >25 years (OR 1.25, 95% CI 0.72–2.17, P = 0.42) and married people had a higher prevalence than unmarried/single people (OR 2.16, 95% CI 1.51–3.10, P < 0.0001). The Egger's test statistics (P = 0.584), Begg and Mazumdar's rank correlation test (P = 0.054) indicated the absence of publication bias. This study analysis reported a low intermediate prevalence of HBV infection (4%) in Bangladesh, which is currently higher than the global prevalence of HBV infection (3.5%).

Keywords: Bangladesh, hepatitis B, meta-analysis, prevalence

Introduction

Hepatitis B is a highly infectious disease caused by the hepatitis B virus (HBV). Despite the availability of an effective vaccine, HBV is considered a major public health problem in developing countries [1]. Globally, around 2.57 billion people are estimated to be infected with HBV and among them, more than 250 million are chronically infected with an increased risk of developing HBV-related liver diseases, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC) [2, 3]. According to the global burden of disease, almost 887 000 deaths occurred in 2015 due to acute and chronic HBV infections and 17%, 40% and 43% of deaths were caused by acute infections, LC and HCC, respectively [2]. The prevalence of HBV infection is highly heterogeneous throughout the world and classified as high prevalence areas wherein more than 8% of the people is positive for hepatitis B surface antigen (HBsAg); high intermediate prevalence areas wherein 5–7.99% of the people HBsAg positive; low intermediate prevalence areas wherein 2–4.99% of the people is HBsAg positive; and low prevalence areas wherein less than 2% of the people is positive for HBsAg [4, 5].

Bangladesh is a densely populated developing nation of South Asia, according to the first report in 1984, the prevalence of HBV infection was 7.60% in Bangladesh and indicated as a country with a high intermediate prevalence of hepatitis B [6]. The major difficulties for hepatitis B elimination in Bangladesh, including a lack of reliable data to guide policy, low awareness and barriers to early diagnosis, transmission via infected blood products, unsafe injections and nosocomial transmission and a lack of treatment availability. However, recent studies from 2005 onwards, reported that the prevalence of HBV infection in Bangladesh is at a decline. In 2003, Bangladesh Government included the hepatitis B vaccine in the Expanded Programme of Immunisation (EPI), intending to provide a timely birth dose to newborn babies. It was identified as the most effective HBV immunisation programme across the country with a reported successful HBV vaccination rate of 95% in children [7]. However, the scenario was different for adults, who were not included in the free vaccination campaign that ran from 2003 to the present day in Bangladesh. According to studies conducted in 1991, 1997, 2008 and 2011, the reported prevalence of hepatitis B were 8.6%, 6.4%, 5.5% and 6.5%, respectively in adults [8]. Besides, details are scarce on the prevalence of HBV infection throughout the general community of Bangladesh and no studies have been carried out at the country level.

Therefore, as there is currently no comprehensive study in this regard in Bangladesh, the present meta-analysis was performed to estimate the current prevalence of HBV infection in the general population of Bangladesh based on the data previously published from 1995 to 2021.

Methods

Literature search strategy

This systematic review and meta-analysis on the prevalence of hepatitis B in Bangladeshi people were conducted according to the guidelines of Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) [9] (Supplementary file 1). The four international databases (PubMed, Google Scholar, Scopus and Web of Science) and the national databases (Bangladesh Journals Online) were searched for all published studies up to April 2021. The following keywords such as ‘hepatitis B’, ‘hepatitis B virus, ‘HBV’, ‘HBsAg’, ‘prevalence’, ‘prevalent’, ‘epidemiology’, ‘Bangladesh’ and ‘Bangladeshi people’ were used during the search. Additionally, the native journals that could not be accessed online were searched manually and unpublished studies were retrieved from the library of Noakhali Science and Technology University, Bangladesh.

Inclusion and exclusion criteria

We adopted cross-sectional studies reporting on the prevalence of hepatitis B in the Bangladeshi people. The listed inclusion criteria were the following: (1) study published in a peer-reviewed journal in English; (2) reported studies were accessible in full text (editorial, conference abstracts, case reports not included); and (3) all articles were published from 1995 to 2021. The exclusion criteria were the following: (1) study published in other languages than English; (2) study populations coinfected with HBV, HCV and HIV and (3) study design with non-random sampling like conducted on blood donors, sex workers and connected to other clinical studies.

Data extraction

The data extraction was conducted independently by three authors (AG, KYG and HD) based on study design and inclusion criteria. After reviewing a full-text article, the following data were extracted from each study including first author name, publication year, year of data collection, study design, sample size, study setting (urban or rural), gender, age, sample size, number of HBsAg positive individuals and HBsAg test methods. Any inconsistencies during the data extraction were solved through careful discussion with other authors (AD and SB).

Quality assessment

For evaluating the quality of all included studies, further, we assessed the articles using the Cross-Sectional/Prevalence Study Quality Assessment Forms which were suggested by the Agency for Healthcare Research and Quality (AHRQ) [10]. This AHRQ form has eleven questions (Supplementary file 2: Table S1), of which ten questions are fitted for cross-sectional studies, and the questions were answered with ‘Yes’, ‘No’ and ‘Unclear’. ‘Yes’ represented a score of 1 and ‘No’ or ‘Unclear’ represented a score of 0. The total score of ten questions in the AHRQ form was used to assess the quality of each article in this systematic review and meta-analysis.

Statistical analysis

The Freeman–Tukey double arcsine transformation of proportions was used to estimate the pooled prevalence of HBV infection [11, 12]. DerSimonian-Laird random-effects models were followed to conduct the meta-analysis with a 95% confidence interval (95% CI). We conducted subgroup analyses on the included studies based on age groups, genders and marital status. The existence of heterogeneity across studies was evaluated using both the Cochrane chi-square Q-test and I2 index with its resultant P-value. A value of I2 25%, 50% and 75% was used to define the heterogeneity of low, medium and high, respectively. Standard error was estimated from the sample size according to Wan et al. [13] method. Finally, the funnel plot was used to assess the possible publication bias graphically and formally by Begg's and Egger's test (significant at P < 0.05). All analyses were carried out by MetaXL software (meta-analysis in Microsoft Excel) and Review Manager 5.4 (RevMan 5.4, the Cochrane Collaboration, Oxford, United Kingdom).

Results

Search result

A total of 225 articles were identified through various databases searches. After the removal of duplicate records, additional screening and analysis of the titles and abstracts, 33 articles were retrieved for final assessment. Among 33 studies, 15 articles met the eligibility criteria and were finally included in the meta-analysis. Figure 1 shows the process of the literature review, screening and eligibility assessment of the study articles.

Fig. 1.

Fig. 1.

Open in a new tab

Flowchart showing the literature searching process of the study according to PRISMA guidelines.

Characteristics of included studies

The included 15 studies with a total sample size of 60 496 reported the prevalence of hepatitis B in Bangladesh and the characteristics of all studies are presented in Table 1. All the included articles [14–28] were cross-sectional studies and conducted throughout the period ranging from 1995 to 2017. The smallest sample size was 130 [14] and the largest sample size was 43 213 [26]. Eight studies were conducted in urban settings [16–19, 21, 25, 26, 28], three in semiurban settings [22, 23, 27], two in rural settings [14, 24] and two studies covered both rural and urban areas [15, 20]. In terms of quality, all studies rated as high quality and had a total quality score higher than 4 (Supplementary file 2: Table S2).

Table 1.

Characteristics of the studies included in the meta-analysis, order by year of publication and alphabetically within the same year

Author, year of publication Year of data collection Study design Study area Age group (years) Sample size (N) HBsAg positive (n) Prevalence of HBsAg (%) Prevalence of anti-HBc (%) Diagnostic method Quality grade
Laskar et al. (1997) 1995 Cross-sectional Urban 11–16 846 7 0.83 – ELISA 4
Rahman et al. (1997) 1994–1995 Cross-sectional Rural ≥ 15 1000 64 6.4 – ELISA 4
Rumi et al. (2000) 1994–1996 Cross-sectional Urban ≥ 20 43 213 1884 4.4 – ELISA 5
Gibney et al. (2001) 1999 Cross-sectional Urban 15–60 388 23 5.9 48.1 ELISA 4
Zaki et al. (2003) 1997–1998 Cross-sectional Urban 0–60 534 16 3.0 21.1 ELISA 5
Alam et al. (2006) 2002–2003 Cross-sectional Rural and urban 0–15 323 23 7.1 – ELISA 6
Mahtab et al. (2008) 2007 Cross-sectional Semi-urban 16–50 1018 56 5.5 – ELISA 6
Ashraf et al. (2010) 2005–2006 Cross-sectional Urban 10–38 1997 130 6.5 – ELISA 5
Mamun-Al-Mahtab et al. (2011) 2010 Cross-sectional Semi-urban 0–60 1018 9 0.88 – ELISA 6
Rudra et al. (2011) 2008–2009 Cross-sectional Urban ≥ 16 2015 126 6.3 – ELISA 5
Yasmin et al. (2011) 2007 Cross-sectional Semi-urban 18–25 146 11 7.5 – ELISA 4
Khan et al. (2012) 1995–2012 Cross-sectional Rural and urban 17–18 1643 5 0.31 – ELISA 4
Afroz et al. (2013) 2012 Cross-sectional Urban 20–60 3971 194 4.9 – ELISA 5
Jobayer et al. (2016) 2013 Cross-sectional Urban 18–45 2254 53 2.4 – ELISA 5
Akhter et al. (2017) 2017 Cross-sectional Rural NA 130 5 3.9 – ELISA 4
Open in a new tab

Meta-analysis

The pooled estimated prevalence of HBV infection in the general people of Bangladesh was 4.0% (95% CI 3.0–5.1) (Fig. 2). The results of the heterogeneity test showed that the included studies were significantly heterogeneous (I2 = 96%, P < 0.0001). Figure 3 shows the results of subgroup analysis of HBV infection among the included studies based on age groups, gender and marital status. The estimated prevalence of hepatitis B was higher in people of age <25 years compared to the people of age >25 years [odds ratio (OR) 1.25, 95% CI 0.72, 2.17, P = 0.42] with heterogeneity I2 78%. The prevalence of hepatitis B was higher in females in comparison to the males (OR 1.20, 95% CI 0.48, 2.97, P = 0.70) with heterogeneity I2 95%. The results also demonstrated that the prevalence of hepatitis B was significantly higher in married people than unmarried/single people (OR 2.16, 95% CI 1.51, 3.10, P < 0.0001) with heterogeneity I2 68%. Finally, the funnel plot (Fig. 4) and Egger's linear regression (P = 0.584) and Begg and Mazumdar's rank correlation test (P = 0.054) for the prevalence of HBV infection indicated that there was no evidence of possible publication bias in all studies.

Fig. 2.

Fig. 2.

Open in a new tab

The pooled prevalence of HBV infection in the general people of Bangladesh.

Fig. 3.

Fig. 3.

Open in a new tab

Sub-group meta-analysis reporting HBV prevalence in Bangladesh. (A) between gender, (B) between age groups and (C) between married and unmarried people.

Fig. 4.

Fig. 4.

Open in a new tab

Funnel plot of the meta-analysis.

HBV infection in Bangladesh over time

Based on the publications included in the present study, we examine the changes in the reported prevalence of HBV infection in the general population of Bangladesh over time (Fig. 5). According to studies, the prevalence of HBV infection in Bangladesh was 7.12% between 2001 and 2003. In Bangladesh, a decreasing trend in the prevalence of HBV infection was seen after the implementation of EPI, which started in 2003. According to the most current research, which was conducted in 2017, the reported prevalence of HBV infection in Bangladesh was 3.85%.

Fig. 5.

Fig. 5.

Open in a new tab

Prevalence trend of HBV infection in Bangladesh over time after the implementation of EPI.

Discussion

Worldwide, hepatitis B is a major public health concern and around 3.5% of people are identified as chronic HBV carriers according to a report of 2015 [29]. To obtain the latest data on the prevalence of hepatitis B in the general population of Bangladesh, this systematic review and meta-analysis were performed based upon the published data in the years 1995–2021. According to our systematic review, the pooled prevalence of HBV infection in the general population of Bangladesh was 4% (95% CI 3.0–5.1), which is considered as a low intermediate prevalence rate and indicated a higher prevalence rate in Bangladesh than the global prevalence rate (3.5%). It is also mentioned that a decreasing trend in the prevalence of HBV infection was observed in Bangladesh after the implementation of EPI, which started in 2003 (Fig. 5). Most of the studies (8 studies) included in the present study showed a prevalence rate in the range of 5–8% (high intermediate prevalence), 4 studies which have a range of 2–4% (low intermediate prevalence) and 3 studies have the prevalence rate <2% (low prevalence) (Fig. 2). The scenario of other Asian countries is also variable in most studies. The reported prevalence rates in South Asian countries like Pakistan, Bhutan and Nepal were 2.76%, 5.84% and 0.9%, respectively [2, 30]. Whereas, the prevalence of hepatitis B was higher in South East Asian countries of Thailand (5.1%) and Malaysia (4%) [31, 32]. In the case of comparison with East Asian countries, China has a higher intermediate prevalence rate (6.89%) [33] and Japan has a lower prevalence rate (1.02%) [2]. Therefore, it is confirmed that the prevalence rate of HBV infection varies significantly with countries and regions. The potential causes for this discrepancy could be due to the socio-cultural status, level of awareness and infection prevention practice by the community of different countries. The identified major factors for a moderate prevalence rate of HBV infection in Bangladesh are lack of education, lack of awareness regarding HBV vaccination, limited reliable data to guide policy, poverty, lack of blood screening/cross-checking, perilous sexual activity, vertical transmission from mother to child, costly treatment of HBV infection and lack of proper health care facilities [7, 34–37].

The findings of the research included in this study are very heterogenous, owing to the fact that they were conducted on a variety of different populations and that the screening methods used were inconsistent. However, subgroup analysis was performed to reduce this heterogeneity and provided more details on HBV infection. According to subgroup analysis, we found people of age <25 years had a 1.25 times higher prevalence of HBV infection than the people of age >25 years (OR 1.25, 95% CI 0.72, 2.17, P = 0.42). Even though younger individuals had greater vaccine coverage, the majority of children and young people had increased prevalence as a consequence of hepatitis B transmission from mother to baby, sexual activity and, most importantly, illegal drug use via intravenous injection. Recent studies reported that drug addiction is much higher among Bangladesh's young than the elderly population [7, 35]. We found hepatitis B was significantly more prevalent in married people than the unmarried/single people (OR 2.16, 95% CI 1.51, 3.10, P < 0.0001). Consistent with this study, a higher prevalence of HBV infection was reported in married people in Iran [38] and Pakistan [39] than the unmarried people due to the lack of awareness and education about sexual practices between husband and wife, as HBV is transported through semen and vaginal secretions [40]. The results of subgroup analysis also revealed that the prevalence of hepatitis B was 1.20 times higher in females than males (OR 1.20, 95% CI 0.48, 2.97, P = 0.70). Women could be infected due to unprotected sex with her husband or partners and during pregnancy, their modified immune system cannot fight against viral hepatitis load [41]. In contrast, a recent study of China reported the prevalence of HBV infection was higher in males than females (5.88% vs. 5.05%) might be due to occupational risk factors, drug usage and male homosexuality [33].

This meta-analysis has the following limitations behind the importance of the study. The prime limitation of this meta-analysis is that most of the articles had a lower number of participants. Secondly, the inconsistency of screening methods might have contributed to the heterogeneity of pooled prevalence estimates. Finally, the information regarding subgroup analysis was only limited to gender, age and marital status, but not included other socio-economic conditions of the participants.

Conclusion

According to our report, Bangladesh has a low intermediate prevalence rate of HBV infection (4.0%) with an inflated prevalence rate in female, married and younger adults. As the analysis covered vast numbers of studies, it represents the existing prevalence and epidemiology of hepatitis B in the country that could be beneficial for public health leaders to decision-makers. More comprehensive research with larger sample sizes should be conducted to improve the understanding and identification of HBV epidemiology in Bangladesh. In order to achieve hepatitis B elimination in Bangladesh, it is recommended to improve the scope of the national immunisation programme to ensure the vaccination of people at all levels.

Financial support

This study didn't receive any specific grant from any organisations like the public or commercial.

Ethical standards

Not required.

Informed consent

No informed consent was necessary.

Supplementary material

For supplementary material accompanying this paper visit http://doi.org/10.1017/S0950268822000061.

hygsup.zip (52KB, zip)

click here to view supplementary material

Conflict of interest

The authors declare no conflict of interest.

Data availability statement

The authors confirm that the datasets used for this study are available on request from the corresponding author.

References

  • 1.Stanaway JD et al. (2016) The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. The Lancet 388, 1081–1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schweitzer A et al. (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet 386, 1546–1555. [DOI] [PubMed] [Google Scholar]
  • 3.Terrault NA et al. (2016) A ASLD guidelines for treatment of chronic hepatitis B. Hepatology 63, 261–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.André F (2000) Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18, S20–S22. [DOI] [PubMed] [Google Scholar]
  • 5.Shepard CW et al. (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiologic Reviews 28, 112–125. [DOI] [PubMed] [Google Scholar]
  • 6.Islam MN et al. (1984) Hepatitis-B virus infection in Dhaka, Bangladesh. Bangladesh Medical Research Council bulletin 10, 1–6. [PubMed] [Google Scholar]
  • 7.Uz-Zaman M et al. (2018) Epidemiology of hepatitis B virus infection in Bangladesh: prevalence among general population, risk groups and genotype distribution. Genes 9, 541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Alam S et al. (2017) Past, present, and future of hepatitis B and fatty liver in Bangladesh. Gastroenterol Hepatol Open Access 6, 197. [Google Scholar]
  • 9.Liberati A et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 62, e1–e34. [DOI] [PubMed] [Google Scholar]
  • 10.Rostom A et al. (2004) Celiac Disease: Summary. AHRQ Evidence Report Summaries. Rockville, MD: Agency for Healthcare Research and Quality. [Google Scholar]
  • 11.Barendregt JJ et al. (2013) Meta-analysis of prevalence. Journal of Epidemiology & Community Health 67, 974–978. [DOI] [PubMed] [Google Scholar]
  • 12.Yuan R et al. (2016) Prevalence of different HIV-1 subtypes in sexual transmission in China: a systematic review and meta-analysis. Epidemiology & Infection 144, 2144–2153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wan X et al. (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology 14, 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Akhter S et al. (2017) Prevalence of hepatitis B virus and hepatitis C virus in a Tea Garden of Bangladesh. Euroasian Journal of Hepato-Gastroenterology 7, 107–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Alam MS et al. (2006) The seroprevalence of hepatitis B virus among children attending urban and rural hospitals. Bangladesh Journal of Child Health 30, 17–21. [Google Scholar]
  • 16.Ashraf H et al. (2010) Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infectious Diseases 10, 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fakruddin M et al. (2013) A retrospective study on seroprevalence of hepatitis B virus surface antigen (HbsAg) among healthy individuals attending a tertiary care clinic in Dhaka, Bangladesh. International Journal of Biomedical Research 4, 245–250. [Google Scholar]
  • 18.Gibney L et al. (2001) Human immunodeficiency virus, hepatitis B, C and D in Bangladesh's trucking industry: prevalence and risk factors. International Journal of Epidemiology 30, 878–884. [DOI] [PubMed] [Google Scholar]
  • 19.Jobayer M et al. (2016) Prevalence of hepatitis B virus, hepatitis C virus, and HIV in overseas job seekers of Bangladesh with the possible routes of transmission. Mymensingh Medical Journal 25, 530–535. [PubMed] [Google Scholar]
  • 20.Khan MK et al. (2012) Prevalence of hepatitis B in admitted students of a Private Medical College. Community Based Medical Journal 1, 3–7. [Google Scholar]
  • 21.Laskar MS et al. (1997) Prevalence of hepatitis B surface antigen (HBsAg) in Viqarunnessa noon girls’ school children in Dhaka, Bangladesh. Central European Journal of Public Health 5, 202–204. [PubMed] [Google Scholar]
  • 22.Mahtab M-A et al. (2008) Epidemiology of hepatitis B virus in Bangladeshi general population. Hepatobiliary & Pancreatic Diseases International 7, 595–600. [PubMed] [Google Scholar]
  • 23.Mamun-Al-Mahtab FK et al. (2011) Prevalence and risk factors of asymptomatic hepatitis C virus infection in Bangladesh. Journal of Clinical and Experimental Hepatology 1, 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rahman M et al. (1997) Sero-epidemiological study of hepatitis B virus infection in a village. Bangladesh Medical Research Council Bulletin 23, 38–41. [PubMed] [Google Scholar]
  • 25.Rudra S et al. (2011) Prevalence of hepatitis B and hepatitis C virus infection in human of Mymensingh, Bangladesh. Mymensingh Medical Journal 20, 183–186. [PubMed] [Google Scholar]
  • 26.Rumi MA et al. (2000) Prevalence of infectious diseases and drug abuse among Bangladeshi workers. Southeast Asian Journal of Tropical Medicine & Public Health 31, 571–574. [PubMed] [Google Scholar]
  • 27.Yasmin R et al. (2011) Hepatitis B virus infection among workers in selected garments. Bangladesh Medical Journal 40, 50–53. [Google Scholar]
  • 28.Zaki MH et al. (2003) Seroepidemiology of hepatitis B and delta virus infections in Bangladesh. Journal of Tropical Pediatrics 49, 371–374. [DOI] [PubMed] [Google Scholar]
  • 29.Asrani SK et al. (2019) Burden of liver diseases in the world. Journal of Hepatology 70, 151–171. [DOI] [PubMed] [Google Scholar]
  • 30.Shedain PR et al. (2018) Hepatitis B infection among indigenous people in Nepal: looking through an equity lens. Nepal Journal of Obstetrics and Gynaecology 13, 5–11. [Google Scholar]
  • 31.Leroi C et al. (2016) Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. International Journal of Infectious Diseases 51, 36–43. [DOI] [PubMed] [Google Scholar]
  • 32.Muhamad NA et al. (2020) Seroprevalence of hepatitis B virus and hepatitis C virus infection among Malaysian population. Scientific Reports 10, 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wang H et al. (2019) Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infectious Diseases 19, 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hasan KN et al. (2017) Prevalence of hepatitis B virus seromarkers and associated risk factors in young healthy individuals in Bangladesh: implications for preventive strategies. Hepatitis Monthly 17, e14245. [Google Scholar]
  • 35.Gani MS et al. (2014) Urban–rural and socioeconomic variations in the knowledge of STIs and AIDS among Bangladeshi adolescents. Asia Pacific Journal of Public Health 26, 182–195. [DOI] [PubMed] [Google Scholar]
  • 36.Zafrin N et al. (2019) Hepatitis b virus infection: knowledge and awareness among the patients admitted in a tertiary care hospital in Bangladesh. Viral Hepatitis Journals 25, 6. [Google Scholar]
  • 37.Sheikh N et al. (2018) Coverage, timelines, and determinants of incomplete immunization in Bangladesh. Tropical Medicine and Infectious Disease 3, 72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fathimoghaddam F et al. (2011) The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepatitis Monthly 11, 346. [PMC free article] [PubMed] [Google Scholar]
  • 39.Basit A et al. (2014) Prevalence of hepatitis B and C infection in Pakistan. Journal of Infection and Molecular Biology 2, 35–38. [Google Scholar]
  • 40.Franco E et al. (2012) Hepatitis B: epidemiology and prevention in developing countries. World Journal of Hepatology 4, 74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Borgia G et al. (2012) Hepatitis B in pregnancy. World Journal of Gastroenterology 18, 4677. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

For supplementary material accompanying this paper visit http://doi.org/10.1017/S0950268822000061.

hygsup.zip (52KB, zip)

click here to view supplementary material

Data Availability Statement

The authors confirm that the datasets used for this study are available on request from the corresponding author.

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES